Lineage Cell Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Lineage Cell Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Lineage Cell Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 255 %, a 15.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 255 -47.7 -15.8% Jun 30, 2024
Q1 2024 264 -36.4 -12.1% Mar 31, 2024
Q4 2023 268 -42.9 -13.8% Dec 31, 2023
Q3 2023 296 +14.9 +5.29% Sep 30, 2023
Q2 2023 302 -15.8 -4.97% Jun 30, 2023
Q1 2023 300 -81.9 -21.4% Mar 31, 2023
Q4 2022 311 -145 -31.8% Dec 31, 2022
Q3 2022 281 -549 -66.1% Sep 30, 2022
Q2 2022 318 -443 -58.2% Jun 30, 2022
Q1 2022 382 -274 -41.8% Mar 31, 2022
Q4 2021 456 -151 -24.9% Dec 31, 2021
Q3 2021 830 +149 +21.8% Sep 30, 2021
Q2 2021 761 -40.8 -5.09% Jun 30, 2021
Q1 2021 656 -42.1 -6.03% Mar 31, 2021
Q4 2020 607 +25.1 +4.3% Dec 31, 2020
Q3 2020 681 +177 +35.1% Sep 30, 2020
Q2 2020 802 +356 +79.8% Jun 30, 2020
Q1 2020 698 +163 +30.5% Mar 31, 2020
Q4 2019 582 -44.3 -7.07% Dec 31, 2019
Q3 2019 504 -148 -22.6% Sep 30, 2019
Q2 2019 446 -110 -19.8% Jun 30, 2019
Q1 2019 535 +139 +35.2% Mar 31, 2019
Q4 2018 626 +284 +83% Dec 31, 2018
Q3 2018 652 +373 +134% Sep 30, 2018
Q2 2018 556 +264 +90.2% Jun 30, 2018
Q1 2018 396 +33.1 +9.14% Mar 31, 2018
Q4 2017 342 +16.2 +4.98% Dec 31, 2017
Q3 2017 279 -71 -20.3% Sep 30, 2017
Q2 2017 292 -39.5 -11.9% Jun 30, 2017
Q1 2017 362 +30.6 +9.23% Mar 31, 2017
Q4 2016 326 -40 -10.9% Dec 31, 2016
Q3 2016 350 -30.7 -8.08% Sep 30, 2016
Q2 2016 332 -24.9 -6.97% Jun 30, 2016
Q1 2016 332 -10.8 -3.16% Mar 31, 2016
Q4 2015 366 +67.8 +22.7% Dec 31, 2015
Q3 2015 380 +185 +94.6% Sep 30, 2015
Q2 2015 357 +157 +78.2% Jun 30, 2015
Q1 2015 343 +139 +68.3% Mar 31, 2015
Q4 2014 298 +63 +26.8% Dec 31, 2014
Q3 2014 195 -69.7 -26.3% Sep 30, 2014
Q2 2014 200 -106 -34.6% Jun 30, 2014
Q1 2014 204 -109 -34.9% Mar 31, 2014
Q4 2013 235 -187 -44.2% Dec 31, 2013
Q3 2013 265 -373 -58.5% Sep 30, 2013
Q2 2013 306 -498 -61.9% Jun 30, 2013
Q1 2013 313 -600 -65.7% Mar 31, 2013
Q4 2012 422 Dec 31, 2012
Q3 2012 638 Sep 30, 2012
Q2 2012 804 Jun 30, 2012
Q1 2012 913 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.